The practice of nerve repair continues to evolve alongside advances in science, surgical technique, and clinical care. Although resources supporting the use of nerve connectors, protectors, and processed allografts in peripheral nerve repair are expanding, literature guiding head and neck reanimation remains limited. Surgeons must optimize outcomes in facial nerve repair while balancing cost, efficiency, […]

Reliable vascular access remains the cornerstone of hemodialysis, yet each patient’s journey through chronic kidney disease is unique. The 2019 Kidney Disease Outcomes Quality Initiative (KDOQI) vascular access guidelines update introduced a patient‑focused strategy that tailors vascular access choices to individual circumstances and personal goals.   As AV graft utilization continues to play a key […]

Although critical to biomedical research and drug development, biospecimen safety and integrity are often overlooked and under-recognized issues. Lack of attention to specimen storage, handling, transport, and tracking can quickly compromise reproducibility, waste irreplaceable samples, and delay clinical progress. In this panel, experts from GenVault discuss proactive strategies for safeguarding valuable biological materials that work […]

In this GEN Biotechnology webinar, Vicky Smith, PhD, an expert in RNA biology, will provide a practical blueprint for enhancing mRNA quality using proven manufacturing strategies from TriLink’s 25+ years of expertise. She will review a range of strategies to optimize critical parameters such as UTR tuning, codon optimization, cap choices, in vitro transcription (IVT) […]

Challenges in traditional ureteroscopy, including poor visibility, stone migration, incomplete stone clearance, and elevated intrarenal pressures, have resulted in a paradigm shift in treatment options for a disease that affects nearly 10% of people worldwide. Specifically, numerous devices have now been developed that focus on aspiration, with expected benefits of enhanced stone clearance and safety. […]

Gastrointestinal (GI) cancer remains one of the deadliest forms of cancer worldwide, with the American Cancer Society predicting about 30,000 new cases and more than 10,000 deaths in the U.S. in 2025. GI cancer relapses remain a major challenge due to small fragments of cancer that persist in the body after a patient has completed […]

In breast cancer care, a recurring clinical dilemma is identifying patients who have residual disease and are at risk of relapse. The ability to detect minimal residual disease (MRD) at the molecular level is emerging as a critical tool for optimizing patient care and outcomes. Growing evidence supports the use of circulating tumor DNA (ctDNA) […]